sennosides, USP 15 MG
RxNorm concept 331425, clinical drug component (scdc).
- RxCUI
- 331425
- Term type
- Clinical drug component (SCDC)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/331425 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- sennosides, USP 15 MG Oral Tablet (SCD, constitutes)
- sennosides, USP 15 MG Chewable Tablet [Ex-Lax Chocolated] (SBD, constitutes)
- sennosides, USP 15 MG Oral Tablet [Ex-Lax Regular Strength Pills] (SBD, constitutes)
- sennosides, USP 15 MG Chewable Tablet (SCD, constitutes)
- sennosides, USP 15 MG Oral Tablet [Perdiem Overnight] (SBD, constitutes)
- sennosides, USP (IN, has ingredient)
- sennosides, USP 15 MG [Ex-Lax Chocolated] (SBDC, has tradename)
- sennosides, USP 15 MG [Ex-Lax Regular Strength Pills] (SBDC, has tradename)
- sennosides, USP 15 MG [Perdiem Overnight] (SBDC, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 331425 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/331425 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 331425. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.